先进机器人血管造影系统在传统经导管动脉化疗栓塞术图像引导中对辐射剂量和图像质量的影响
这项回顾性研究纳入106例行传统经导管动脉化疗栓塞术(C-TACE)的肝脏恶性肿瘤患者,比较第一代与第二代机器人血管造影平台在透视和数字减影血管造影(DSA)中的辐射剂量与图像质量。结果显示第二代系统透视和DSA的剂量面积乘积均显著低于第一代,且DSA和透视图像质量评分分别提高30%和76%,读者间一致性良好至优秀。
要点
- 第二代机器人血管造影系统透视剂量面积乘积为1.4 ± 1.1 Gy·cm,显著低于第一代的2.8 ± 3.4 Gy·cm(P = 0.001)。
- 第二代系统DSA剂量面积乘积为2.2 ± 1.2 Gy·cm,显著低于第一代的4.7 ± 2.3 Gy·cm(P = 0.003)。
- 第二代系统DSA图像质量评分较第一代提高30%(P = 0.004),透视图像质量评分提高76%(P = 0.001)。
核心结论
- 最新一代机器人血管造影设备在C-TACE的透视和DSA图像引导中可实现显著的辐射剂量降低,同时提高图像质量。
研究设计与样本
- 回顾性研究纳入106例(57女/49男,平均年龄60 ± 11岁)行C-TACE的肝脏恶性肿瘤患者,分为第一代(n=53)和第二代(n=53)机器人血管造影平台组;辐射剂量用电离室测量,图像质量由3名放射科医师采用5点Likert量表评估。
诊断标准与关键数值
- 第二代较第一代系统改进包括精细晶体探测器系统增强降噪和先进CARE滤过软件降低辐射剂量;图像质量采用5点Likert量表评估,读者间一致性Fleiss kappa第一代κ = 0.75、第二代κ = 0.74。
临床应用与阅片要点
- 在C-TACE图像引导中,第二代机器人血管造影系统可降低透视和DSA的辐射剂量并提升图像质量,阅片和报告中可关注剂量面积乘积和图像质量评分的变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to compare 2 advanced robotic angiography systems for real-time image guidance in terms of radiation dose and image quality (IQ) during conventional transarterial chemoembolization (C-TACE) of hepatic malignant tumors.
MATERIALS AND METHODS: One hundred six patients (57 women/49 men; mean age, 60 ± 11 years) who had undergone C-TACE using 2 generations of robotic angiography platforms for image guidance were included in this retrospective study. Patients were divided into 2 groups (n = 53, respectively): group 1 (first generation) and group 2 (second generation). Radiation dose for fluoroscopy and digital subtraction angiography (DSA) was compared between first-generation and second-generation angiography equipment, respectively. Among several features of the second-generation compared with the first-generation system, improvements included a refined crystalline detector system for enhanced noise reduction and advanced CARE filter software for lowering radiation dose. Radiation dose was measured using an ionization chamber. Image quality was assessed by 3 radiologists using 5-point Likert scales.
RESULTS: Both groups were comparable in terms of number and location of lesions, as well as body weight, body mass index, and anatomical variants of feeding hepatic arteries (all P > 0.05). Dose-area product (DAP) for fluoroscopy was significantly lower in group 2 (1.4 ± 1.1 Gy·cm) compared with group 1 (2.8 ± 3.4 Gy·cm; P = 0.001). For DSA, DAP was significantly lower (P = 0.003) in group 2 (2.2 ± 1.2 Gy·cm) versus group 1 (4.7 ± 2.3 Gy·cm). Scores for DSA IQ indicated significant improvements for group 2 by 30% compared with group 1 (P = 0.004). Regarding fluoroscopy, scores for IQ were 76% higher in group 2 compared with group 1 (P = 0.001). Good to excellent interrater agreement with Fleiss kappa coefficients of κ = 0.75 for group 1 and κ = 0.74 for group 2 were achieved.
CONCLUSIONS: Most recent generation robotic angiography equipment allows for considerable radiation dose reductions while improving IQ in fluoroscopy and DSA image guidance during C-TACE treatment.
引用
- Vogl TJ, Alizadeh LS, Maeder R, et al. Advanced Robotic Angiography Systems for Image Guidance During Conventional Transarterial Chemoembolization: Impact on Radiation Dose and Image Quality. Invest Radiol. 2019. PMID: 30444795. doi:10.1097/RLI.0000000000000519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。